What are Cancer Vaccines?

After the successful implementation of vaccines in preventing infectious diseases decades ago, scientists and researchers are now focusing to create cancer vaccines. This is an emerging area in the field of oncology that could transform how some cancers can be prevented, treated, and monitored. Essentially, cancer vaccines are a kind of immunotherapy treatment that trains the body’s immune system to recognize and destroy cancer cells. There are some vaccines already in use such as human papillomavirus (HPV) and hepatitis B which helps in preventing certain cancers by putting a check on the infections that cause them in the first place.

How Cancer Vaccines Work

While some cancer vaccines help in cancer prevention, others are designed to treat already existing cancers. These vaccines use more than one of the below approaches:

• Targets virus-infected cancer cells: Cancer cells affected by virus have viral antigens. Using vaccines, these antigens are easily recognized and attacked by the immune system.

• Recognizes cancer antigens: The abnormally high amounts of proteins produced by cancer cells often act as a signal for cancer vaccines to help your immune system detect and respond to them.

• Targets cancer-only changes: Often, cancer cells carry cancer-specific changes, including genetic mutations which vaccines can specifically target, while leaving the healthy tissues untouched.

• Boosts immune activity: Cancer cells can bypass immune detection while vaccines can activate multiple parts of the immune system to enhance the immune response against these cells.

The Role of mRNA Technology

RNA-based cancer vaccines are a breakthrough in cancer treatment that has leveraged advances in mRNA technology and precision medicine approaches. The notable period from 2024-2025 has been pivotal in the development of RNA cancer vaccines. Current mRNA platforms include conventional mRNA, trans-amplifying RNA, self-amplifying RNA, and emerging circular RNA technologies. It is anticipated that by 2029, RNA cancer vaccines will become the cornerstone on which personalized oncology will be built. 

Recent developments in circular mRNA vaccines have shown their potential to retain immunogenic potency post lyophilization and storing capacity at standard refrigeration temperatures. On the other hand, self-amplifying mRNAs exhibit sustained antigen expression and enhanced immunogenicity, making them suitable for cancer treatments. Compared to conventional mRNA vaccines, these self-amplifying mRNAs incorporate viral replication machinery. Due to this machinery, intracellular amplification of tumor antigen-encoding mRNA provides prolonged immune stimulation with lower initial doses.

Do cancer vaccines have side effects?

Side effects caused by cancer vaccines are somewhat different from those associated with some other cancer treatment such as chemotherapy, radiation, etc. The reason behind this is that vaccines work by activating the immune system rather than directly destroying cancer cells. Common side effects caused due to cancer vaccines include anorexia, chills with fever, fatigue, headache, joint pains, nausea, etc. The type of side effect linked to a particular cancer vaccine depends on the location and type of cancer, what it targets, and overall health of the patient. 

Artificial Intelligence (AI) and the Future of Vaccine Design 

The integration of AI with CRISPR technology has led to a massive transformation in the advancement of RNA cancer vaccine development. CRISPR clinical trials include applications in cancer immunotherapy, where CRISPR-engineered CAR-T cells and gene editing approaches are used in combination with RNA vaccines. This allows genetic modifications which can drive optimized T-cell responses to vaccine-delivered tumor antigens. Using this approach, quick iteration and testing of RNA vaccine designs is now possible. 

With advances in mRNA technology, genomic sequencing, artificial intelligence, and immunotherapy, new avenues in the field of cancer vaccines are now feasible. While significant challenges still remain to vaccine development, the future holds great promise for cancer patients, offering them hope and long-lasting immune protection. Clinical trials are under way which use a combination of RNA vaccines with multiple checkpoint inhibitors, cellular immunotherapy, and targeted therapies. Continual researches in cancer vaccine development, along with regulatory support will securely place cancer vaccine integration in the upcoming times. It is high time conventional cancer treatments took a backseat and vaccines are ushered as the novel hope for cancer patients worldwide.

Preventing liver cancer begins with prevention of hepatitis B infection. It is important to understand that hepatitis B vaccination offers life-long protection for most people. Thus, getting vaccinated against HBV will significantly reduce the risk of serious complications such as cirrhosis and hepatocellular carcinoma. Talk to your healthcare provider about your liver health and vaccination status. It is high time we rise together to reduce the burden of liver cancer from our society through vaccination and regular screening.